Abstract
Heme catabolism by heme oxygenase (HO) with a decrease in intracellular heme concentration and a concomitant local release of CO and Fe2+ has potential to regulate BKCa channels. Here we show that the iron-based photolabile CO-releasing molecule CORM-S1 [dicarbonyl-bis(cysteamine)iron(II)] co-releases CO and Fe2+, making it a suitable light-triggered source of these downstream products of HO activity. To investigate the impact of CO, iron and cysteamine on BKCa channel activation, human Slo1 (hSlo1) was expressed in HEK293T cells and studied with electrophysiological methods. Whereas hSlo1 channels are activated by CO and even more strongly by Fe2+, Fe3+ and cysteamine possess only marginal activating potency. Investigation of hSlo1 mutants revealed that Fe2+ modulates the channels mainly through the Mg2+-dependent activation mechanism. Flash photolysis of CORM-S1 suits for rapid and precise delivery of Fe2+ and CO in biological settings.
Keywords: Flash photolysis, heme, ferrous iron, carbon monoxide, ion channel, patch clamp
INTRODUCTION
Heme degradation by heme oxygenase (HO), including the inducible enzyme HO-1 and the constitutive form HO-2, results in the formation of biliverdin, ferrous iron (Fe2+) and carbon monoxide (CO).1 Biliverdin is known for its antioxidant and antiviral properties,2, 3 and is further broken down to bilirubin via the activity of biliverdin reductase. Fe2+ is typically considered a co-factor for protein function within either iron/sulfur clusters or heme. When liberated during heme catabolism, Fe2+ has oxidative potential but was so far considered an inconsequential by-product, most likely because of scavenging by ferritin and iron transport mechanisms.4 CO, although toxic at high concentration, meanwhile is accepted as an important gaseous signaling molecule.5
The vasodilatory effects of CO led to the hypothesis that CO may be a biological mediator of cellular functions.6 This hypothesis is supported in various animal models of human diseases.7 CO contributes to important physiological functions including the regulation of vascular smooth muscle tone and blood pressure, suppression of inflammation, and protection against ischemia, septic shock and hypoxia.8 The induction of HO-1 under stress conditions strongly hinted that endogenously produced CO had a beneficial or therapeutic effect.9, 10 These findings have established CO as an important gaseous messenger molecule akin to NO and H2S.11
To fully realize the promise of CO as a therapeutic agent, a key challenge is to find novel routes of CO delivery specifically to diseased tissues in need of treatment. Several CO vehicles, so-called CO-releasing molecules (CORMs), have therefore been developed.7, 12, 13 To enable a safe and site-specific administration of CO, CORMs releasing CO only upon tailored triggers should be beneficial. CORM-S1 [dicarbonyl-bis(cysteamine)iron(II)] (SFigure 1A) holds this promise as this compound liberates CO under illumination with visible light (SFigure 2).14 Furthermore, because CORM-S1 is based on ferrous iron, it is expected that illumination results in liberation of CO, Fe2+, and cysteamine, the latter of which being an endogenously produced breakdown product of coenzyme A.15 Therefore, to some degree CORM-S1 may constitute a light-triggered mimic of HO activity.
In physiological experiments, CORM-S1 activates CO-sensitive ion channels in a light-dependent manner including large-conductance Ca2+- and voltage-dependent K+ channels (BKCa, MaxiK, KCa, KCa1.1).14 BKCa channels open in response to an increase in intracellular Ca2+ concentration to μM levels and/or membrane depolarization, typically providing a negative feedback influence on cellular excitability.16 The channels are found in almost every tissue and their physiological roles are well documented in many phenomena, including regulation of smooth muscle tone, determination of action potential duration and neurotransmitter release.16 Dysfunction of BKCa channels is associated with multiple human diseases.17–21 While activation of BKCa channels promotes vascular relaxation, channel inhibition leads to vascular constriction.22 Consistent with this framework, CO released from CORMs was shown to dilate blood vessels by opening of BKCa channels in smooth muscle cells.6
BKCa channels are composed of four pore-forming α subunits encoded by the Slo1 gene (KCNMA1 in humans). Each subunit contains 7 transmembrane segments (S0-S6) and a large C-terminal cytoplasmic region,16 which harbors two homologous structural domains, RCK1 and RCK2.23 Four sets of RCK1/RCK2 dimers form the “gating ring” of BKCa channels.24 Recently determined cryo-EM structural models based on Aplysia Slo1 and human Slo1 (hSlo1) provide insight into the molecular arrangements of the functional domains.25, 26 Each subunit possesses 3 structurally and functionally distinct divalent cation sensors: RCK1 sensor in the gating ring, RCK2 sensor in the gating ring (“Ca2+ bowl“), and the lower-affinity so-called Mg2+ sensor encompassing both the transmembrane domain and the gating ring. The cytosolic gating-ring domain harbors multiple regulatory sites 27 including those for the primary activating ions Ca2+ and Mg2+.28, 29 In addition, H+,12 Zn2+,30 and CO 31, 32 can augment channel activation. Some transition metal ions have also been reported to interfere with BKCa channels.33 Contradictory reports on the impact of Fe2+ on BKCa channels34, 35 ask for a closer examination using improved experimental protocols.
Modulation of BKCa channels by small molecular compounds may be particularly important in the carotid body where the channels are inhibited during hypoxia, thus promoting cell depolarization, Ca2+ influx, and transmitter release.36, 37 A key link between hypoxia and BKCa activity appears to be HO-2, which is postulated to be closely associated with the channel and serves as an oxygen sensor of native and recombinant hSlo1 BKCa complexes.38 However, the molecular mechanism by which HO-2 activity affects BKCa channel function is unclear. Besides the alteration of the pool of available heme, the downstream products CO and Fe2+ may have signaling function when delivered close to the target. While CO has a large diffusional radius, Fe2+ is subject to an intricate buffer system and moreover may be oxidized to Fe3+, both aspects asking for molecular tools for deliberate release of Fe2+ at specific sites of action.
Here we studied how hSlo1 BKCa channels are activated by heme breakdown products by using CORM-S1 and examined if this CO-releasing compound might serve as a chemical and physiological tool to concurrently deliver CO and Fe2+. In particular, we address to what extent BKCa channels are subject to regulation by Fe2+ ions.
RESULTS AND DISCUSSION
CORM-S1 is a Light-Triggered Releaser of CO and Fe2+
Dicarbonyl-bis(cysteamine)iron(II) (CORM-S1, SFigure 1A) was introduced as a photosensitive CO-releasing molecule 14 and, hence, it might be an easy-to-use tool for studying the impact of CO on physiological systems. Moreover, CORM-S1 is expected to liberate Fe2+ upon illumination. In this respect, this low-molecular weight compound should mimic the activity of HO to produce CO and Fe2+ with the advantage of light serving as a direct trigger. We therefore compared the stimulation of light-exposed CORM-S1 on excised membrane patches with hSlo1 BKCa channels using either fluoride solutions (KF) or EGTA-buffered solution; the latter is expected to more efficiently chelate both Ca2+ and Fe2+ ions in solution. KF, in contrast, selectively eliminates Ca2+ by precipitating it as CaF2. While illumination of CORM-S1 potently increased the hSlo1 BKCa currents at 100 mV in KF solutions (Figure 1A, B), it only resulted in a small activating effect with a slow onset in EGTA solutions (Figure 1B). The residual increase in current was similar in magnitude and kinetics to what was previously observed for the application of CO gas.31 To infer about the redox state of iron released from CORM-S1 upon illumination, we investigated the liberation of Fe2+ ions using a photometric assay of 1 mM 1,10-phenanthroline, which upon binding of Fe2+ forms ferroin. This reaction was monitored as a change in absorbance at 510 nm (Figure 1C). Control recordings showed that CORM-S1 did not noticeably release Fe2+ in the absence of light during an experiment of 3 min (Figure 1C). For quantitative analysis of Fe2+ release from CORM-S1, a ferroin calibration curve with FeSO4 was acquired (Figure 1D). Illumination of CORM-S1 samples resulted in comparable ferroin absorption values as FeSO4 samples at the same concentration (Figure 1D), suggesting a full release of the central iron of CORM-S1 as Fe2+.
Figure 1.
Activation of hSlo1 BKCa channels by light-exposed CORM-S1. (A) Current recordings (bottom) in the inside-out patch-clamp configuration of HEK293T cells expressing hSlo1 BKCa channels for the indicated pulse protocol (top) before (Control) and after 1-min light exposure of 50 μM CORM-S1 in KF intracellular solutions. (B) Time course of relative current at 100 mV in the presence of 50 μM CORM-S1 for the indicated light stimulation (bar) in KF solutions (open circles) and in EGTA (10 mM)-buffered solutions (filled circles). Straight lines connect data points for clarity. The dashed horizontal line denotes 1. (C) Analysis of iron released from CORM-S1 in a cuvette measured by the absorbance at 510 nm of ferroin. 50 μM CORM-S1 was dissolved in KF solution containing 1 mM 1,10-phenanthroline. Samples with (blue) or without (gray) illumination as indicated. Error bars are smaller than the symbol size. (D) Fe2+/1,10-phenanthroline calibration curve (triangles) in KF solution with a superimposed linear fit (red line). The maximal OD510 nm after illumination of CORM-S1 (from C) is depicted as blue circle (mean ± standard error, SEM, n = 3).
For an application of CORM-S1 in a physiological setting, it is mandatory to know the kinetics of CO/Fe2+ release and ascertain stability of the compound in the physiological buffers used. We therefore assayed the CO release using a myoglobin absorption assay 14 under various conditions. When illuminated with white light, CORM-S1 rapidly releases two CO molecules, and termination of illumination immediately stops the release (SFigure 1C). The release kinetics was described with a single-exponential function with a time constant of 50 ± 1 s (n = 4) when the measurements were performed in PBS with CORMs dissolved from dry samples immediately before use. When stored as frozen stock solutions in DMSO for up to 48 days, CORM-S1 retained its activity (SFigure 1E). Freshly prepared, CORM-S1 released CO to a maximal extent regardless of whether it was dissolved in PBS or in EGTA- or KF-solutions; the latter buffers were used in subsequent physiological assays (SFigure 1E). In comparison, the commonly used CO releaser CORM-2 (tricarbonyldichlororuthenium(II) dimer) is considerably less stable in storage (SFigure 1B, D, F). Thus, CORM-S1 is a rapid light-triggered releaser of CO and Fe2+ with long-term stability in DMSO, making it a valuable and easy-to-use tool in physiological research. While CO release from CORM-2 is strongly accelerated by the presence of dithionite,39 the breakdown of CORM-S1 entirely relies on illumination, thus justifying the use of the myoglobin release assay (SFigure 1).
Activation of BKCa Channels by CO and Fe2+
BKCa channels are likely down-stream targets of HO; one of its reaction products, CO, can activate these channels.31, 32 Because Fe2+ is also released when HO breaks down heme, we tested the effect of Fe2+ on excised inside-out membrane patches from HEK293T cells expressing hSlo1. In KF solution, i.e. with a very low concentration of free Ca2+, membrane depolarization to 100 mV opens a small fraction of channels (Popen ~ 2%). Application of 100 μM Fe2+ (from an FeSO4 stock solution at low pH, 0.1 N HCl) increased channel activity by about 25-fold (Figure 2A). Application of an equivalent amount of HCl did not affect the channels (data not shown). The time course of the current at 100 mV, normalized to control conditions, is shown in Figure 2A, B; a rapid and robust increase in current is followed by a slower (time constant about 120 s) decline of current size. The latter phenomenon might be attributed to progressive oxidation of Fe2+ to Fe3+ and subsequent precipitation of iron(III)-hydroxide (FeO(OH)), which is insoluble in water, since all experiments were performed under ambient conditions. Fe2+ stability assays in the same KF buffer used for patch-clamp experiments showed an about 5-fold slower decrease in the Fe2+ concentration (SFigure 3A-C), presumably because greater availability of oxygen in an open cell-culture dish compared to a test tube; for stability of Fe2+ under anoxic conditions, see SFigure 3D.
Figure 2.
Effects of CORM-S1 breakdown products on hSlo1 BKCa channels. (A) Current recordings in the inside-out patch-clamp configuration of HEK293T cells expressing hSlo1 BKCa channels for the indicated pulse protocol before (Control) and after application of 100 μM Fe2+ solution to the intracellular side. (B) Time course of the current at 100 mV relative to the control value (I / Icontrol) with application of 100 μM Fe2+ solutions at time zero. (C-F) Time course of the relative current at 100 mV upon application of 100 μM Fe2+ in the presence of 500 μM reduced GSH (C), 100 μM Fe3+ (from FeCl3) (D), 400 μM cysteamine (E), and 200 μM CO gas dissolved in buffer (F). Straight lines connect data points in B-F for clarity. Internal solutions in A-D were fluoride-buffered, and in E-F EGTA-buffered. Data points in B-F are means ± standard error (SEM) with n in parentheses.
Oxidation of Fe2+ to Fe3+ is slowed by reducing agents. We therefore performed experiments with 100 μM Fe2+ in the presence of 500 μM reduced glutathione (GSH) and found a fractional BKCa current increase of about 12 (compared to a factor of 25 without GSH) (Figure 2C). GSH alone also augmented the currents by a factor of 2. Further, the current increase was much more sustained (time constant about 230 s; Figure 2C). Application of 100 μM Fe3+ (from a FeCl3 stock solution) only marginally increased BKCa currents (Figure 2D). Thus, hSlo1 BKCa channels are preferentially activated by Fe2+ but not by Fe3+.
Besides CO and Fe2+, breakdown of CORM-S1 also produces cysteamine, which was ineffective in activating hSlo1 BKCa channels (Figure 2E). Application of CO gas dissolved in the recording buffer (200 μM) only slowly increased the current by a factor of 2 (Figure 2F), as previously reported.31 The fractional increase in current by CO gas was similar in magnitude as the hSlo1 BKCa activation observed with illuminated CORM-S1 in the presence of EGTA (Figure 1B). Taken together, CORM-S1 exerts its activating effect on BKCa channels primarily via Fe2+ ions, while CO plays a secondary role, and cysteamine has almost no impact on channel function.
Fe2+ Activates BKCa Channels via Ca2+- and Mg2+-Binding Sites
Because of the limited redox stability of Fe2+ under ambient conditions (Figure 2), the activating effect of Fe2+ on BKCa channels was rapidly quantified by measuring currents in response to voltage ramps. Described with a Boltzmann function and a linear ion-permeation characteristic (Equation 1, Figure 3A), a shift in the half-maximal activation voltage (ΔV0.5) was extracted as our primary data-description parameter. ΔV0.5 was measured at pH 7.4 for various Fe2+ concentrations yielding a half-maximal effective concentration, EC50, of 25 μM and a maximum shift of about –45 ± 5 mV (n = 6; Figure 3B). This EC50 value is an upper limit because the real concentration of free Fe2+ must be lower: some Fe2+ is expected to be oxidized and to precipitate as FeO(OH). Because of the stability of Fe2+ inside the CORM-S1 complex, using CORM-S1 as a light-triggered source of Fe2+ will be a preferential tool for studying Fe2+ effects on biological systems, particularly at physiological pH which strongly favors oxidation and precipitation of Fe2+ as FeO(OH).
Figure 3.
pH-dependent hSlo1 BKCa activation by Fe2+. (A) bottom Current recordings of hSlo1 BK channels at pH 7.4 upon stimulation with a voltage ramp (−60 to 240 mV in 150 ms) before (Control) and after application of 100 μM Fe2+ to the intracellular side with superimposed fits (red; Eq. 1), used to estimate the shift in half-maximal activation voltage, ΔV0.5. top Fractional current change with Fe2+ application. (B) ΔV0.5 as a function of [Fe2+] with superimposed Hill fit (Eq. 2). Fit parameters were: EC50 = 25 μM, nH = 1.5, ΔV0.5, max = −50 mV. (C, D) Data as for A and B at pH 6.8. Fit parameters in D were nH = 0.7, ΔV0.5, max = −29 mV, EC50 = 5 μM.
Overall, the effect of Fe2+ on BKCa channels is reminiscent of the effects exerted by H+ and divalent cations, such as Ca2+, Mg2+ and Zn2+.27, 30, 40, 41 We therefore tested whether Fe2+-mediated BKCa activation is sensitive to the intracellular pH. As shown in Figure 3C and D, hSlo1 BKCa activation by Fe2+ was weaker at pH 6.8 (as compared to pH 7.4) with a maximum shift in V0.5 of –27 ± 2 mV (n = 6). However, the half-maximal activation concentration was 5 μM, indicating a higher affinity. At pH 6.0, 100 μM Fe2+ only marginally activated hSlo1 BKCa channels with a ΔV0.5 of –5 ± 2 mV (n = 5). At pH 8.0 the maximal Fe2+-induced shift was not much greater than that at pH 7.4, ΔV0.5 = –48 ± 7 mV (n = 5).
To infer the mechanism of Fe2+-mediated channel activation, we compared ΔV0.5 obtained with 100 μM Fe2+ for hSlo1 BKCa wild-type channels with those found for various mutants with modified cation sensors. The double mutation H365A:H394A in the RCK1 domain impairs activation of BKCa channels by intracellular H+ and CORM-2; 31, 32 H365A eliminates the activating effect of Zn2+.30 While the double mutation H365A:H394A diminished the channel activation by CORM-2 to a factor of 2 originating from the released CO,31 ΔV0.5 obtained with Fe2+ was only marginally affected (Figure 4B).
Figure 4.
Structural requirements for BKCa channel activation by Fe2+. (A) Topological model of a hSlo1 BKCa channel α subunit with the transmembrane region and the cytosolic RCK1 and RCK2 regulatory domains. Residues important for channel activation by H+ (green: H365, H394), Mg2+ (magenta: D99, N172, E374, E399), and Ca2+ (blue/red: M513, E535 in RCK1; black: D894 and D895 in RCK2) are indicated. (B) Shifts in half-maximal activation voltage induced by 100 μM Fe2+ for hSlo1 wild type (top) and the indicated channel mutants. ΔCB refers to the deletion of D894 and D895, and HA:HA to the double mutation H365A:H394A. n values are indicated in parentheses. * p < 0.05 and ** p < 0.01 for a test versus the wild-type channel after post-hoc Bonferroni correction.
We furthermore utilized the mutants M513I and E535A known to selectively impair the RCK1 Ca2+-sensor site:42 ΔV0.5 values of these mutants for Fe2+ were only half as large as for the wild type (Figure 4B). In the two-residue deletion mutant ∆D894:D895, the RCK2 “Ca Bowl” Ca2+ sensor is not functional (ΔCB; 43); ΔV0.5 induced in this mutant by Fe2+ was only 50% of that for the wild type (Figure 4B). Even with the mutations designed to disrupt both the RCK1 and RCK2 Ca2+ sensors ([dummy]∆CB:M513I and ∆CB:E535A), about 50% of ΔV0.5 found in the wild type remained. In contrast, the mutations D99R, N172R, E374R, and E399A, each of which disrupt the activation effect of mM levels of intracellular Mg2+,27, 28 rendered the channels almost insensitive to Fe2+ (Figure 4B). The ΔV0.5 by Fe2+ was essentially absent in ∆CB:E399A with the impaired Mg2+ and RCK2 Ca2+ sensors. The mutagenesis results show that the effects of Fe2+ on V0.5 are complex, affecting all three divalent cation sensors in a non-additive manner. However, because those mutations affecting the low-affinity so-called Mg2+ sensor markedly diminish Fe2+-induced ΔV0.5, the Mg2+ site must play a major role.
Activation of BKCa channels by Mg2+ requires voltage-sensor activation.41 We tested whether BKCa channels can be activated by Fe2+ when the voltage sensors are preferentially in the resting state by recording single-channel events at –100 mV. In fact, voltage-sensor activation does not seem to be required for the activation of BKCa channels by Fe2+ (SFigure 4), indicating that the action of Fe2+ similar to that of Ca2+.40 However, while activation of BKCa channels by Ca2+ is augmented by inclusion of human Slo β1 subunits,44 Fe2+-mediated current increase of BKCa channels containing human Slo β1 subunits was not enhanced compared to homomeric hSlo1 BKCa channels (SFigure 5A, B), and ΔV0.5 for channel activation was even smaller (SFigure 5C). Taken together, these results show that Fe2+ ions bind to and enhance activity of BKCa channels in a complex manner with some similarity and differences to Mg2+ and Ca2+ ions.
To test whether physiologically relevant concentrations of Mg2+ may attenuate BKCa activation by Fe2+, F– was replaced with Cl– because F– also precipitates Mg2+. To minimize the concentration of contaminating Ca2+, which is not eliminated by precipitation as CaF2 under these conditions, would become a confounding factor, a solution containing 2 mM MgCl2 was produced from ultrapure salts and water. Under such conditions, which resemble a physiological situation under which BKCa channels are exposed to about μM levels of free Ca2+ and ~2 mM Mg2+, 100 μM Fe2+, either directly added from an FeSO4 stock solution or photoreleased from 100 μM CORM-S1, induced a shift in BKCa V0.5 by –52.6 mV and of –59.6 mV (n = 6), respectively (Figure 5). Such shifts in V0.5 are indistinguishable from those obtained in fluoride-based solutions (e.g., Figure 4C). Therefore, photoreleased Fe2+ from CORM-S1 retains the potential of activating BKCa channels even in a physiological environment with potentially competing Mg2+ ions because Fe2+ has a much higher affinity to the target sites than Mg2+.
Figure 5.
Fe2+ activates hSlo1 BKCa channels in the presence of competing Ca2+ and Mg2+. (A) bottom Representative inside-out patch current recordings in response to stimulation with a voltage ramp (−60 to 190 mV in 125 ms) in a near-physiological internal solutions with 2 mM Mg2+ and about 2 μM Ca2+ at pH 7.4 before (black) and after application of 100 μM FeSO4 to the intracellular side (brown). top Fractional current change with Fe2+ application. (B) Similar data as in (A) with application of 100 μM CORM-S1 and 5-s illumination with blue light (450−490 nm bandpass, 100-W HBO lamp, 40× objective) (blue). Ramp currents were fit as in Figure 3 to determine mean ΔV0.5 values: −52.6 ± 0.2 mV for 100 μM Fe2+; −59.7 ± 0.3 mV for Fe2+ released from 100 μM CORM-S1. In fluoride-buffered solutions 100 μM Fe2+ yielded ΔV0.5 of −45.5 ± 0.5 mV (n = 6 for all).
CORM-S1, a Tool for Rapid Release of Fe2+ and CO
Due to the low solubility and stability of Fe2+ under ambient conditions, its physiological reactions are difficult to study. To overcome this problem, CORM-S1 may serve as a useful light-triggered Fe2+ releaser. Using a flash of light of about 500 μs in duration 45 passed through a GFP excitation filter (450–490 nm), we measured the change in transmission through the bath solution viewed with a 20× objective. With 100 μM CORM-S1 and 2 mM 1,10-phenanthroline in the bath of KF solution, a single light flash resulted in a rapid decrease in transmitted light, which saturated after about 5 ms (Figure 6A, top, green traces). In similar experiments with hSlo1 BKCa channel-containing inside-out patches in the focus of the objective and 100 μM CORM-S1 (no phenanthroline) in the bath, BKCa channels were first preactivated with voltage steps to 120 mV to reach a Popen of a few %. A single light flash then caused a rapid increase in current, well characterized by a single exponential function with time constant of about 60 ms (Figure 6A, bottom). Since Fe2+ release from CORM-S1 was much faster, this time course therefore must reflect binding of Fe2+ to the channel and/or subsequent channel gating. The current-voltage relationship of BKCa channels determined with voltage-ramp stimulations revealed that a single light flash in 100 μM CORM-S1 solutions resulted in a ΔV0.5 of –52 mV (Figure 6B, C), i.e. slightly more than that obtained when 100 μM Fe2+ was applied directly. This indicates that in the focus volume of the microscope objective a single light flash quantitatively photolyzes all CORM-S1. Figure 6C also illustrates that Fe2+ results in current decline at high voltages, presumably because of voltage-dependent open-channel block.
Figure 6.
Rapid release of Fe2+ by flash photolysis of CORM-S1. (A) Representative experiments to illustrate flash photolysis of CORM-S1 (100 μM) and its effect on BKCa currents in inside-out patches. The green trace (top) shows transmission (20× objective) through a 2-mM 1,10-phenanthroline solution. A light flash of about 500 μs duration, passed through a GFP filter set, was applied as indicated by the dashed vertical line. As Fe2+ is released, absorbance increases within a few ms. (bottom) BKCa currents recorded from inside-out patches with step depolarization to 120 mV from −60 mV (solution without 1,10-phenanthroline) with the pipette tip positioned in the focus of the microscope objective for the same application of flash light as above. The time course of additional channel activation was fit with a single-exponential function with time constant of 67 ms, superimposed in red. (right) Expanded time range as also indicated by the gray bar in the left panel. (B) Ramp currents before and after a flash with fractional current increase at the top. (C) Mean normalized conductance (n = 3, standard error, SEM, in shading) shows that a single flash results in a ΔV0.5 of about −52 mV, i.e. about as much as was obtained with direct application of 100 μM Fe2+.
CORM-S1 can also be photolyzed using a cold light source or conventional shuttered light from a mercury lamp passed through a GFP filter set (SFigure 6). The results are qualitatively similar to those obtained with short-duration light flashes (Figure 6). However, at low light intensities or only short exposure, the kinetics of Fe2+ release may become rate-limiting when using BKCa channel activation as readout. As exemplified for BKCa channels, light-triggered decomposition of CORM-S1 may also be used as a sole source of CO if the released Fe2+ ions are readily chelated (e.g. by EGTA) (Figures 1, 2).
Despite the sensitivity of CORM-S1 to visible (blue/cyan, 450–500 nm) light, it remains stable for several days when frozen in DMSO, and even in physiological buffer under ambient temperature the compound retains its efficaciousness for several minutes (SFigure 3E). This stability of CORM-S1 is in contrast with the widely used CORM-2, which spontaneously releases its CO in DMSO, even in frozen stock solutions (SFigure 1).
The biological impact of free Fe2+ is difficult to investigate under ambient conditions, but Fe2+ is much more stable while integrated in CORM-S1. Utilizing a principle applied for the triggered release of Ca2+ from, e.g., DM-nitrophen,46 the results here show that photorelease of Fe2+ from CORM-S1 is a preferred method for transiently supplying Fe2+ in biological settings.
Mechanism of BKCa Channel Activation by Fe2+
Our results clearly show that Fe2+, but not Fe3+, potently activates BKCa channels. For Fe2+ released by flash photolysis from 100 μM CORM-S1 in < 5 ms, the resulting channel activation time constant of about 60 ms (Figure 6) reflects binding of Fe2+ to the channel protein and/or the subsequent channel gating leading to pore opening. Channel activation is mainly brought about by an Fe2+-induced shift in half-maximal activation voltage by about –50 mV. As for BKCa channel activation by Zn2+,30 voltage-sensor activation was not required and ΔV0.5 was diminished by lowering pH (Figure 3B, D). Yet, the molecular determinants for the Fe2+-dependent channel activation clearly differ from those for protons and Zn2+: the histidine mutants H365A and H365A:H394A completely eliminate activation by Zn2+ and protons 32, 47 but not by Fe2+. The observed lower EC50 for Fe2+ for the activation shift at low pH may therefore involve other sites or result from allosteric protein modulation. Similarly, the affinities of the Ca2+ sensors are modulated by voltage and the state of the channel gate.27, 42, 48
Opening of BKCa channels is mainly enhanced by two physiological divalent cations, Ca2+ and Mg2+, working through different structural and functional mechanisms. Ca2+ with the ionic radius of ~1 Å binds to the divalent cation sensors located in the RCK1 and RCK2 domains with estimated affinities in the low μM range.40, 48 The Ca2+-dependent activation of the channel is independent of voltage-sensor activation.41 In contrast, Mg2+, with the smaller ionic radius of ~0.72 Å, is coordinated in the interdomain space between the transmembrane and the cytoplasmic gating ring domains,26 and the activating effect of Mg2+ at mM levels requires voltage-sensor activation.41 Our mutagenesis results targeting the aforementioned three divalent cation sensors suggest that the activating effect of Fe2+ encompasses all three divalent cation sensor sites in a non-additive manner. However, because those mutations targeting the Mg2+-coordinating residues essentially eliminate the Fe2+ action on ΔV0.5 (Figure 4), we postulate that Fe2+ primarily but not exclusively works through the so-called interdomain Mg2+ sensor site, yet without the strict requirement of voltage-sensor activation. The ionic radius and the dehydration enthalpy of Mg2+, 0.72 Å and 1926 kJ/mol, are similar to those of Fe2+, 0.77 Å and 1950 kJ/mol. It is perhaps not surprising that Mg2+ and Fe2+ may activate the channels in part through a common mechanism. Considering that the mM levels of Mg2+ are required to engage the interdomain Mg2+ sensor but that less than 100 μM of Fe2+ is sufficient, for this site, Fe2+ is clearly a higher-affinity ligand, by up to 100-fold. The ΔV0.5 by 100 μM Fe2+ (∆V0.5 = –50 mV) is, however, smaller than that by 10 mM Mg2+ (~–100 mV).41 The observed selective activation by Fe2+ over Fe3+ is probably explained by the smaller ionic radius and the greater hydration enthalpy of Fe3+, 0.65 Å and 4429 kJ/mol, rendering coordination of Fe3+ by the channel much less likely.
Our mutagenesis results collectively suggest that Fe2+ has potential to influence the three main Ca2+ and Mg2+ sensors. We suggest that the interdomain Mg2+ sensor may be the primary target of Fe2+. We cannot, however, exclude potential secondary effects of Fe2+, for example redox changes affecting channel gating because BKCa channels are dependent on the redox conditions in a complex manner.12
BKCa Channels are Targets of Local Fe2+ Concentration Increases
BKCa channels are multimodal targets of heme and heme degradation products. Intracellular heme has inhibitory effects on the channel at positive voltages,49 while it promotes channel opening under hyperpolarized conditions.50 Here we have demonstrated that Fe2+, which is co-released along with CO when heme oxygenase cleaves the protoporphyrin ring of heme, activates BKCa channels with greater efficacy than CO. Considering that HO-2 and Slo1 may be in close proximity of each other,51 Fe2+ generated by the action of HO-2 has potential to reach the BKCa channels where the activating efficacy is greater than that of CO. Local Fe2+, escaping scavenging by ferritin or other Fe2+-binding proteins, may reach the μM range. Taken the previous results and those presented here together, heme catabolism by HO-2 has potential to effect a trilateral impact on BKCa channels: (i) local removal of the channel modulator heme, (ii) liberation of the potential channel activator CO, whose action may depend on the presence of heme,52 and (iii) release of Fe2+ to activate the channels in part via the Mg2+-binding sites. Further, heme itself or to an even greater extent the liberated local Fe2+ may catalyze Fenton reactions such that redox processes may have an additional impact on the channel function.
Another scenario for physiologically relevant BKCa activation by Fe2+ is iron release from lysosomes. BKCa channels have been shown to alleviate lysosomal storage disease by providing a positive feedback loop: lysosomal Ca2+, locally released via TRPML1 channels, directly activated co-localized BKCa channels.53 The resulting K+ influx into the lysosomes counteracts the depolarization resulting from Ca2+ efflux, thereby maintaining an electrochemical gradient for Ca2+. A similar mechanism involving Fe2+ instead of Ca2+ is likely because TRPML1 channels have been shown to release Fe2+ from the very reducing lysosomes.54
The exact contributions of all above-mentioned components in the heme degradation pathway on the channel function are difficult to predict a priori because their effects strongly depend on the overall cellular redox status and the iron buffer capacity of the cytosol. However, ferrous iron needs to be considered a local messenger molecule, presumably in all cells that harbor heme oxygenases and/or specific Fe2+ transport systems, and target molecules, besides BKCa channels, of local changes in Fe2+ concentrations remain to be investigated.
METHODS
Spectrophotometric Measurements
Sample illumination was performed using a cold light source (20 W halogen lamp, Osram GZX4) with 2 W output power at the end of the light guide, which was placed 20 mm above a 1-ml cuvette.
The CO release from CORM-S1 was measured in a spectrophotometric assay as described previously 55 by monitoring absorbance changes on conversion of deoxymyoglobin (Mb) to the myoglobin-CO complex (MbCO). Myoglobin (10 mM) in phosphate-buffered saline (PBS, in mM: 137 NaCl, 2.7 KCl, 10 Na2HPO4, 2 KH2PO4, pH 7.4) was converted to Mb by addition of 0.1% sodium dithionite (Na2S2O4), present during all spectrophotometric measurements. The time course of MbCO formation was monitored by measuring the absorbance at either 422 nm or 540 nm every 10 s. Absorbance changes were converted into CO release based on the difference in absorbance at 540 nm of 100 μM Mb or at 422 nm of 10 μM Mb (in PBS) of CO-free solutions and MbCO (in CO-saturated PBS), corresponding to 100% CO release from 50 μM or 5 μM CORM-S1, respectively.
For spectrophotometric detection of Fe2+, 1 mM 1,10-phenanthroline was dissolved in KF solution, consisting of (in mM): 100 KF, 40 KCl, 10 HEPES (pH 7.4). 1,10-phenanthroline forms stable complexes with free Fe2+ (ferroin), which was detected by measuring the absorbance at 510 nm.56 For Fe2+ release experiments, 50 μM CORM-S1 was dissolved in KF buffer containing 1 mM 1,10-phenanthroline. Time course of Fe2+ release from CORM-S1 was monitored by measuring the absorbance at 510 nm at intervals of 15 s with 12 s of illumination in between. For Fe2+ calibration, FeSO4 was dissolved to the respective concentration in KF buffer with 1 mM 1,10-phenanthroline.
Flash Photolysis of CORM-S1
Rapid photolysis of CORM-S1 was achieved with a discharge xenon arc lamp (UV flash lamp, T.I.L.L. Photonics). Light was passed through an epifluorescence GFP filter set (BP 470/40 HE; FT 495 HE) and a 20– objective (NA 0.75, fluar). A single flash had a peak intensity of about 2.2 kW/cm2 and a half-width duration of 500 μs.45 Bandpass-filtered transmission light (BP 520/15) was measured with a photodiode (FDU photodiode with view finder, T.I.L.L. Photonics). The kinetics of Fe2+ release from CORM-S1 was estimated by measuring the transmission through the bath solution (about 2 mm path length) with additional 2 mM 1,10-phenanthroline in the bath because Fe2+ binds to phenanthroline and increases absorbance.
Chemicals
CORM-S1 (CAS 127589–49-5) was prepared as described previously 55 and stored under nitrogen. All other chemicals were from Sigma.
Channel Constructs and Mutagenesis
Pore-forming channel subunits of human Slo1 (hSlo1 α, KCNMA1, acc. no. U11058), were subcloned in a pCI-neo-vector (Promega). Mutations were introduced by PCR-based methods. All constructs were verified by DNA sequencing.
Cell Culture
HEK293T cells (CAMR) were cultured in Dulbecco’s modified Eagle’s medium containing 45% Ham’s F12 medium (PAA) and supplemented with 10% fetal bovine serum in a 5% CO2 incubator at 37 °C.
Cells were trypsinized, diluted with culture medium, and seeded on 12-mm glass coverslips one day prior to transfection. Electrophysiological experiments were performed 1–3 days after transfection. Cells were transfected with the respective plasmids using the Rotifect (Roth) transfection reagent. Co-transfection of a plasmid coding for CD8 was used for identification of transfected cells by means of anti-CD8-coated microbeads (Dynabeads, Deutsche Dynal GmbH).
Electrophysiological Measurements
Inside-out patch-clamp experiments were performed at 20–23 °C using an EPC-10 patch-clamp amplifier controlled via PatchMaster software (both from HEKA Elektronik). Patch pipettes fabricated from borosilicate filament glass had resistances from 1 to 3 MΩ when used with the solutions described below. Current recordings were low-pass filtered at 10 kHz and sampled at 50–100 kHz. Linear leak was subtracted using a p/4 protocol. The standard internal “EGTA” solution contained (in mM): 140 KCl, 10 EGTA, 10 HEPES (pH 7.4 with KOH). Alternatively, KF solution was used (see above). External solution (in mM): 140 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES (pH 7.4 with KOH). For the application of chemical compounds, appropriate amounts of freshly prepared stock solutions (100 mM FeSO4 or FeCl3 in 0.1 N HCl and 50 mM CORM-S1 in DMSO) were added directly to the internal solution. Illumination of CORM-S1 was performed similarly to the myoglobin assay. Voltage dependence, measured with ramp protocols, was quantified by fitting the currents (I(V)) assuming a linear single-channel current and a Boltzmann function for the open probability:
| (1) |
Gmax is the maximal conductance, Erev the reversal potential, k the Boltzmann constant, T the absolute temperature, V0.5 the half-maximal activation voltage, and qapp the apparent gating charge.
Shifts in half-maximal activation voltage (ΔV0.5) as a function of Fe2+ concentration was described with a Hill equation:
| (2) |
ΔV0.5,max is the maximally obtained shift, EC50 the half-maximal effective concentration, c the concentration, and nH the Hill coefficient.
For experiments probing competition between Fe2+ and Ca2+/Mg2+, a solution containing (in mM) 140 KCl, 2 MgCl2 and 10 HEPES (pH 7.4 with KOH) was prepared from ultrapure compounds and water. Based on the voltage dependence of BKCa channel activation, the free Ca2+ concentration in these solutions was estimated to be about 2 μM.
Data Analysis
Data were analyzed with FitMaster (HEKA Elektronik) and IgorPro (WaveMetrics). Averaged data are presented as means ± standard error (SEM) (n, number of independent measurements). Averaged data were compared with a two-sided Student’s t test assuming unequal variances, followed by a Bonferroni post-hoc correction, when appropriate.
Supplementary Material
ACKNOWLEDGEMENTS
This work was supported by the German Research Foundation (FOR1738/P3, P4, P7, HE2993/16) (S.H.H., M.W., T.H.), the Ernst Abbe Foundation (S.H.H.), and the National Institutes of Health (R01GM121375) (T.H.). We also thank A. Hammerschmidt for technical assistance.
Abbreviations
- CO
carbon monoxide
- CORMs
carbon monoxide releasing molecules
- ΔCB
deletion of D894 and D895 in hSlo1
- EGTA
ethyleneglycol-bis(β-aminoethyl)-N,N,N’,N’-tetraacetic acid
- GFP
green fluorescent protein
- GSH
glutathione
- H2S
hydrogen sulfide
- HEPES
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- HO
heme oxygenase
- hSlo1
human Slo1
- NO
nitric oxide
- RCK(1/2)
regulators of conductance for K+
Footnotes
Supporting Information
Long-term stability assays for CORM-S1 and CORM-2, wavelength dependence of CO release from CORM-S1, stability of Fe2+ and CORM-S1 in physiological solutions, impact of Fe2+ on hSlo1 single-channel recordings at low voltages, activation of hSlo1 channels by Fe2+ in the presence of Slo β1, activation of hSlo BKCa channels by light triggered rapid release of Fe2+.
REFERENCES
- 1.Maines MD, The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997, 37, 517–54. [DOI] [PubMed] [Google Scholar]
- 2.Jansen T; Daiber A, Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase? Front Pharmacol 2012, 3, 30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lehmann E; El-Tantawy WH; Ocker M; Bartenschlager R; Lohmann V; Hashemolhosseini S; Tiegs G; Sass G, The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 2010, 51 (2), 398–404. [DOI] [PubMed] [Google Scholar]
- 4.Gao G; Li J; Zhang Y; Chang YZ, Cellular iron metabolism and regulation. Adv Exp Med Biol 2019, 1173, 21–32. [DOI] [PubMed] [Google Scholar]
- 5.Wegiel B; Hanto DW; Otterbein LE, The social network of carbon monoxide in medicine. Trends Mol Med 2013, 19 (1), 3–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Leffler CW; Parfenova H; Jaggar JH, Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol 2011, 301 (1), H1–h11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Motterlini R; Mann BE; Foresti R, Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005, 14 (11), 1305–18. [DOI] [PubMed] [Google Scholar]
- 8.Gullotta F; di Masi A; Coletta M; Ascenzi P, CO metabolism, sensing, and signaling. Biofactors 2012, 38 (1), 1–13. [DOI] [PubMed] [Google Scholar]
- 9.Fagerlund MJ; Kahlin J; Ebberyd A; Schulte G; Mkrtchian S; Eriksson LI, The human carotid body: expression of oxygen sensing and signaling genes of relevance for anesthesia. Anesthesiology 2010, 113 (6), 1270–9. [DOI] [PubMed] [Google Scholar]
- 10.Wu ML; Ho YC; Lin CY; Yet SF, Heme oxygenase-1 in inflammation and cardiovascular disease. Am J Cardiovasc Dis 2011, 1 (2), 150–8. [PMC free article] [PubMed] [Google Scholar]
- 11.Szabo C, Gaseotransmitters: new frontiers for translational science. Sci Transl Med 2010, 2 (59), 59ps54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hou S; Heinemann SH; Hoshi T, Modulation of BKCa channel gating by endogenous signaling molecules. Physiology (Bethesda) 2009, 24, 26–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yan H; Du J; Zhu S; Nie G; Zhang H; Gu Z; Zhao Y, Emerging delivery strategies of carbon monoxide for therapeutic applications: from CO gas to CO releasing nanomaterials. Small 2019, 15 (49), e1904382. [DOI] [PubMed] [Google Scholar]
- 14.Kretschmer R; Gessner G; Görls H; Heinemann SH; Westerhausen M, Dicarbonyl-bis(cysteamine)iron(II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1). J Inorg Biochem 2011, 105 (1), 6–9. [DOI] [PubMed] [Google Scholar]
- 15.Besouw M; Masereeuw R; van den Heuvel L; Levtchenko E, Cysteamine: an old drug with new potential. Drug Discov Today 2013, 18 (15–16), 785–92. [DOI] [PubMed] [Google Scholar]
- 16.Salkoff L; Butler A; Ferreira G; Santi C; Wei A, High-conductance potassium channels of the SLO family. Nat Rev Neurosci 2006, 7 (12), 921–31. [DOI] [PubMed] [Google Scholar]
- 17.Du W; Bautista JF; Yang H; Diez-Sampedro A; You SA; Wang L; Kotagal P; Luders HO; Shi J; Cui J; Richerson GB; Wang QK, Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 2005, 37 (7), 733–8. [DOI] [PubMed] [Google Scholar]
- 18.Wang B; Rothberg BS; Brenner R, Mechanism of increased BK channel activation from a channel mutation that causes epilepsy. J Gen Physiol 2009, 133 (3), 283–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.N’Gouemo P, BKCa channel dysfunction in neurological diseases. Front Physiol 2014, 5, 373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bailey CS; Moldenhauer HJ; Park SM; Keros S; Meredith AL, KCNMA1-linked channelopathy. J Gen Physiol 2019, 151 (10), 1173–1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Du X; Carvalho-de-Souza JL; Wei C; Carrasquel-Ursulaez W; Lorenzo Y; Gonzalez N; Kubota T; Staisch J; Hain T; Petrossian N; Xu M; Latorre R; Bezanilla F; Gomez CM, Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proc Natl Acad Sci U S A 2020, 117 (11), 6023–6034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nelson MT; Cheng H; Rubart M; Santana LF; Bonev AD; Knot HJ; Lederer WJ, Relaxation of arterial smooth muscle by calcium sparks. Science 1995, 270 (5236), 633–7. [DOI] [PubMed] [Google Scholar]
- 23.Jiang Y; Lee A; Chen J; Cadene M; Chait BT; MacKinnon R, Crystal structure and mechanism of a calcium-gated potassium channel. Nature 2002, 417 (6888), 515–22. [DOI] [PubMed] [Google Scholar]
- 24.Yusifov T; Savalli N; Gandhi CS; Ottolia M; Olcese R, The RCK2 domain of the human BKCa channel is a calcium sensor. Proc Natl Acad Sci U S A 2008, 105 (1), 376–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Tao X; Hite RK; MacKinnon R, Cryo-EM structure of the open high-conductance Ca2+-activated K+ channel. Nature 2017, 541 (7635), 46–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tao X; MacKinnon R, Molecular structures of the human Slo1 K+ channel in complex with beta4. Elife 2019, 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Xia XM; Zeng X; Lingle CJ, Multiple regulatory sites in large-conductance calcium-activated potassium channels. Nature 2002, 418 (6900), 880–4. [DOI] [PubMed] [Google Scholar]
- 28.Shi J; Krishnamoorthy G; Yang Y; Hu L; Chaturvedi N; Harilal D; Qin J; Cui J, Mechanism of magnesium activation of calcium-activated potassium channels. Nature 2002, 418 (6900), 876–80. [DOI] [PubMed] [Google Scholar]
- 29.Zhang G; Huang SY; Yang J; Shi J; Yang X; Moller A; Zou X; Cui J, Ion sensing in the RCK1 domain of BK channels. Proc Natl Acad Sci U S A 2010, 107 (43), 18700–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hou S; Vigeland LE; Zhang G; Xu R; Li M; Heinemann SH; Hoshi T, Zn2+ activates large conductance Ca2+-activated K+ channel via an intracellular domain. J Biol Chem 2010, 285 (9), 6434–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Gessner G; Sahoo N; Swain SM; Hirth G; Schönherr R; Mede R; Westerhausen M; Brewitz HH; Heimer P; Imhof D; Hoshi T; Heinemann SH, CO-independent modification of K+ channels by tricarbonyldichlororuthenium(II) dimer (CORM-2). Eur J Pharmacol 2017, 815, 33–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hou S; Xu R; Heinemann SH; Hoshi T, The RCK1 high-affinity Ca2+ sensor confers carbon monoxide sensitivity to Slo1 BK channels. Proc Natl Acad Sci U S A 2008, 105 (10), 4039–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhou Y; Zeng XH; Lingle CJ, Barium ions selectively activate BK channels via the Ca2+-bowl site. Proc Natl Acad Sci U S A 2012, 109 (28), 11413–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Leinders T; van Kleef RG; Vijverberg HP, Divalent cations activate small- (SK) and large-conductance (BK) channels in mouse neuroblastoma cells: selective activation of SK channels by cadmium. Pflugers Arch 1992, 422 (3), 217–22. [DOI] [PubMed] [Google Scholar]
- 35.Oberhauser A; Alvarez O; Latorre R, Activation by divalent cations of a Ca2+-activated K+ channel from skeletal muscle membrane. J Gen Physiol 1988, 92 (1), 67–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lewis A; Peers C; Ashford ML; Kemp PJ, Hypoxia inhibits human recombinant large conductance, Ca2+-activated K+ (maxi-K) channels by a mechanism which is membrane delimited and Ca2+ sensitive. J Physiol 2002, 540 (Pt 3), 771–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Peers C, Hypoxic suppression of K+ currents in type I carotid body cells: selective effect on the Ca2+-activated K+ current. Neurosci Lett 1990, 119 (2), 253–6. [DOI] [PubMed] [Google Scholar]
- 38.Kemp PJ, Hemeoxygenase-2 as an O2 sensor in K+ channel-dependent chemotransduction. Biochem Biophys Res Commun 2005, 338 (1), 648–52. [DOI] [PubMed] [Google Scholar]
- 39.McLean S; Mann BE; Poole RK, Sulfite species enhance carbon monoxide release from CO-releasing molecules: implications for the deoxymyoglobin assay of activity. Anal Biochem 2012, 427 (1), 36–40. [DOI] [PubMed] [Google Scholar]
- 40.Horrigan FT; Aldrich RW, Coupling between voltage sensor activation, Ca2+ binding and channel opening in large conductance (BK) potassium channels. J Gen Physiol 2002, 120 (3), 267–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Horrigan FT; Ma Z, Mg2+ enhances voltage sensor/gate coupling in BK channels. J Gen Physiol 2008, 131 (1), 13–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bao L; Rapin AM; Holmstrand EC; Cox DH, Elimination of the BKCa channel’s high-affinity Ca2+ sensitivity. J Gen Physiol 2002, 120 (2), 173–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Schreiber M; Salkoff L, A novel calcium-sensing domain in the BK channel. Biophys J 1997, 73 (3), 1355–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Orio P; Latorre R, Differential effects of β1 and β2 subunits on BK channel activity. J Gen Physiol 2005, 125 (4), 395–411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ojha NK; Jin J; Arifin JC; Rühl P; Heinemann SH, Membrane potential manipulation with visible flash lamp illumination of targeted microbeads. Biochem Biophys Res Commun 2019, 517 (2), 297–302. [DOI] [PubMed] [Google Scholar]
- 46.Györke S; Vélez P; Suárez-Isla B; Fill M, Activation of single cardiac and skeletal ryanodine receptor channels by flash photolysis of caged Ca2+. Biophys J 1994, 66 (6), 1879–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hou S; Horrigan FT; Xu R; Heinemann SH; Hoshi T, Comparative effects of H+ and Ca2+ on large-conductance Ca2+- and voltage-gated Slo1 K+ channels. Channels (Austin) 2009, 3 (4), 249–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Sweet TB; Cox DH, Measurements of the BKCa channel’s high-affinity Ca2+ binding constants: effects of membrane voltage. J Gen Physiol 2008, 132 (5), 491–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Tang XD; Xu R; Reynolds MF; Garcia ML; Heinemann SH; Hoshi T, Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 2003, 425 (6957), 531–5. [DOI] [PubMed] [Google Scholar]
- 50.Horrigan FT; Heinemann SH; Hoshi T, Heme regulates allosteric activation of the Slo1 BK channel. J Gen Physiol 2005, 126 (1), 7–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Williams SE; Wootton P; Mason HS; Bould J; Iles DE; Riccardi D; Peers C; Kemp PJ, Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004, 306 (5704), 2093–7. [DOI] [PubMed] [Google Scholar]
- 52.Jaggar JH; Li A; Parfenova H; Liu J; Umstot ES; Dopico AM; Leffler CW, Heme is a carbon monoxide receptor for large-conductance Ca2+-activated K+ channels. Circ Res 2005, 97 (8), 805–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Cao Q; Zhong XZ; Zou Y; Zhang Z; Toro L; Dong XP, BK channels alleviate lysosomal storage diseases by providing positive feedback regulation of lysosomal Ca2+ release. Dev Cell 2015, 33 (4), 427–41. [DOI] [PubMed] [Google Scholar]
- 54.Dong XP; Cheng X; Mills E; Delling M; Wang F; Kurz T; Xu H, The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 2008, 455 (7215), 992–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Velasquez VPL; Jazzazi TMA; Malassa A; Görls H; Gessner G; Heinemann SH; Westerhausen M, Derivatives of photosensitive CORM-S1-CO complexes of iron and ruthenium with the (OC)2M(S-C-C-NH2)2 fragment. Eur J Inorg Chem 2012, (7), 1072–1078. [Google Scholar]
- 56.Tamura H; Goto K; Yotsuyanagi T; Nagayama M, Spectrophotometric determination of iron(II) with 1,10-phenanthroline in the presence of large amounts of iron(III). Talanta 1974, 21 (4), 314–8. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






